 | • レポートコード：MRC2102QY13419 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の低分子医薬品有効成分市場について種類別（標準API、高効力API）、用途別（循環器疾患、呼吸器疾患、感染症、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・低分子医薬品有効成分市場の概要 ・世界の主要地域別低分子医薬品有効成分市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の低分子医薬品有効成分市場規模2015-2026：種類別（標準API、高効力API） ・世界の低分子医薬品有効成分市場規模2015-2026：用途別（循環器疾患、呼吸器疾患、感染症、その他） ・低分子医薬品有効成分の米国市場規模2015-2020 ・低分子医薬品有効成分のヨーロッパ市場規模2015-2020 ・低分子医薬品有効成分の中国市場規模2015-2020 ・低分子医薬品有効成分の日本市場規模2015-2020 ・低分子医薬品有効成分の東南アジア市場規模2015-2020 ・低分子医薬品有効成分のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・低分子医薬品有効成分の製造コスト分析 ・販売チャネル、流通業者、顧客 ・低分子医薬品有効成分の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Small Molecule Active Pharmaceutical Ingredient Market
The global Small Molecule Active Pharmaceutical Ingredient market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Small Molecule Active Pharmaceutical Ingredient Scope and Market Size
The global Small Molecule Active Pharmaceutical Ingredient market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Small Molecule Active Pharmaceutical Ingredient market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Small Molecule Active Pharmaceutical Ingredient market is segmented into
Standard API
High Potency API
Segment by Application, the Small Molecule Active Pharmaceutical Ingredient market is segmented into
Cardiovascular Diseases
Respiratory Disorders
Infectious Diseases
Others
The Small Molecule Active Pharmaceutical Ingredient market is analysed and market size information is provided by regions (countries). Segment by Application, the Small Molecule Active Pharmaceutical Ingredient market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Small Molecule Active Pharmaceutical Ingredient Market Share Analysis
Small Molecule Active Pharmaceutical Ingredient market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Small Molecule Active Pharmaceutical Ingredient business, the date to enter into the Small Molecule Active Pharmaceutical Ingredient market, Small Molecule Active Pharmaceutical Ingredient product introduction, recent developments, etc.
The major vendors covered:
Johnson Matthey
Siegfried Holding AG
Pfizer
Sanofi S.A.
Novartis AG,
Bristol-Myers Squibb
Boehringer Ingelheim GmbH
GlaxoSmithKline
Albany Molecular Research Inc.
Bachem Holding AG
PCAS
Patheon N.V.
AstraZeneca
Johnson & Johnson
Merck & Co
BASF SE
Catalent Inc.
Teva Pharmaceuticals
Roche
Cambrex Corporation
GILEAD Science Inc.
1 Small Molecule Active Pharmaceutical Ingredient Market Overview
1.1 Small Molecule Active Pharmaceutical Ingredient Product Scope
1.2 Small Molecule Active Pharmaceutical Ingredient Segment by Type
1.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales by Type (2020-2026)
1.2.2 Standard API
1.2.3 High Potency API
1.3 Small Molecule Active Pharmaceutical Ingredient Segment by Application
1.3.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Comparison by Application (2020-2026)
1.3.2 Cardiovascular Diseases
1.3.3 Respiratory Disorders
1.3.4 Infectious Diseases
1.3.5 Others
1.4 Small Molecule Active Pharmaceutical Ingredient Market Estimates and Forecasts (2015-2026)
1.4.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2026)
1.4.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (2015-2026)
1.4.3 Global Small Molecule Active Pharmaceutical Ingredient Price Trends (2015-2026)
2 Small Molecule Active Pharmaceutical Ingredient Estimate and Forecast by Region
2.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Small Molecule Active Pharmaceutical Ingredient Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region (2015-2020)
2.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region (2015-2020)
2.3 Global Small Molecule Active Pharmaceutical Ingredient Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Small Molecule Active Pharmaceutical Ingredient Estimates and Projections (2015-2026)
2.4.2 Europe Small Molecule Active Pharmaceutical Ingredient Estimates and Projections (2015-2026)
2.4.3 China Small Molecule Active Pharmaceutical Ingredient Estimates and Projections (2015-2026)
2.4.4 Japan Small Molecule Active Pharmaceutical Ingredient Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Small Molecule Active Pharmaceutical Ingredient Estimates and Projections (2015-2026)
2.4.6 India Small Molecule Active Pharmaceutical Ingredient Estimates and Projections (2015-2026)
3 Global Small Molecule Active Pharmaceutical Ingredient Competition Landscape by Players
3.1 Global Top Small Molecule Active Pharmaceutical Ingredient Players by Sales (2015-2020)
3.2 Global Top Small Molecule Active Pharmaceutical Ingredient Players by Revenue (2015-2020)
3.3 Global Small Molecule Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Active Pharmaceutical Ingredient as of 2019)
3.4 Global Small Molecule Active Pharmaceutical Ingredient Average Price by Company (2015-2020)
3.5 Manufacturers Small Molecule Active Pharmaceutical Ingredient Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Small Molecule Active Pharmaceutical Ingredient Players (Opinion Leaders)
4 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Type
4.1 Global Small Molecule Active Pharmaceutical Ingredient Historic Market Review by Type (2015-2020)
4.1.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
4.1.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Type (2015-2020)
4.1.3 Global Small Molecule Active Pharmaceutical Ingredient Price by Type (2015-2020)
4.2 Global Small Molecule Active Pharmaceutical Ingredient Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Type (2021-2026)
4.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Type (2021-2026)
4.2.3 Global Small Molecule Active Pharmaceutical Ingredient Price Forecast by Type (2021-2026)
5 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Application
5.1 Global Small Molecule Active Pharmaceutical Ingredient Historic Market Review by Application (2015-2020)
5.1.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
5.1.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Application (2015-2020)
5.1.3 Global Small Molecule Active Pharmaceutical Ingredient Price by Application (2015-2020)
5.2 Global Small Molecule Active Pharmaceutical Ingredient Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Application (2021-2026)
5.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Application (2021-2026)
5.2.3 Global Small Molecule Active Pharmaceutical Ingredient Price Forecast by Application (2021-2026)
6 United States Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures
6.1 United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company (2015-2020)
6.2 United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
6.3 United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
7 Europe Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures
7.1 Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company (2015-2020)
7.2 Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
7.3 Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
8 China Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures
8.1 China Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company (2015-2020)
8.2 China Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
8.3 China Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
9 Japan Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures
9.1 Japan Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company (3015-3030)
9.2 Japan Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
9.3 Japan Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
10 Southeast Asia Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures
10.1 Southeast Asia Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
11 India Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures
11.1 India Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company (2015-2020)
11.2 India Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
11.3 India Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Small Molecule Active Pharmaceutical Ingredient Business
12.1 Johnson Matthey
12.1.1 Johnson Matthey Corporation Information
12.1.2 Johnson Matthey Business Overview
12.1.3 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Products Offered
12.1.5 Johnson Matthey Recent Development
12.2 Siegfried Holding AG
12.2.1 Siegfried Holding AG Corporation Information
12.2.2 Siegfried Holding AG Business Overview
12.2.3 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Products Offered
12.2.5 Siegfried Holding AG Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Small Molecule Active Pharmaceutical Ingredient Products Offered
12.3.5 Pfizer Recent Development
12.4 Sanofi S.A.
12.4.1 Sanofi S.A. Corporation Information
12.4.2 Sanofi S.A. Business Overview
12.4.3 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Products Offered
12.4.5 Sanofi S.A. Recent Development
12.5 Novartis AG,
12.5.1 Novartis AG, Corporation Information
12.5.2 Novartis AG, Business Overview
12.5.3 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Products Offered
12.5.5 Novartis AG, Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Corporation Information
12.6.2 Bristol-Myers Squibb Business Overview
12.6.3 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Boehringer Ingelheim GmbH
12.7.1 Boehringer Ingelheim GmbH Corporation Information
12.7.2 Boehringer Ingelheim GmbH Business Overview
12.7.3 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Products Offered
12.7.5 Boehringer Ingelheim GmbH Recent Development
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Corporation Information
12.8.2 GlaxoSmithKline Business Overview
12.8.3 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.8.4 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Products Offered
12.8.5 GlaxoSmithKline Recent Development
12.9 Albany Molecular Research Inc.
12.9.1 Albany Molecular Research Inc. Corporation Information
12.9.2 Albany Molecular Research Inc. Business Overview
12.9.3 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Products Offered
12.9.5 Albany Molecular Research Inc. Recent Development
12.10 Bachem Holding AG
12.10.1 Bachem Holding AG Corporation Information
12.10.2 Bachem Holding AG Business Overview
12.10.3 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Products Offered
12.10.5 Bachem Holding AG Recent Development
12.11 PCAS
12.11.1 PCAS Corporation Information
12.11.2 PCAS Business Overview
12.11.3 PCAS Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.11.4 PCAS Small Molecule Active Pharmaceutical Ingredient Products Offered
12.11.5 PCAS Recent Development
12.12 Patheon N.V.
12.12.1 Patheon N.V. Corporation Information
12.12.2 Patheon N.V. Business Overview
12.12.3 Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Products Offered
12.12.5 Patheon N.V. Recent Development
12.13 AstraZeneca
12.13.1 AstraZeneca Corporation Information
12.13.2 AstraZeneca Business Overview
12.13.3 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.13.4 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Products Offered
12.13.5 AstraZeneca Recent Development
12.14 Johnson & Johnson
12.14.1 Johnson & Johnson Corporation Information
12.14.2 Johnson & Johnson Business Overview
12.14.3 Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Products Offered
12.14.5 Johnson & Johnson Recent Development
12.15 Merck & Co
12.15.1 Merck & Co Corporation Information
12.15.2 Merck & Co Business Overview
12.15.3 Merck & Co Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Merck & Co Small Molecule Active Pharmaceutical Ingredient Products Offered
12.15.5 Merck & Co Recent Development
12.16 BASF SE
12.16.1 BASF SE Corporation Information
12.16.2 BASF SE Business Overview
12.16.3 BASF SE Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.16.4 BASF SE Small Molecule Active Pharmaceutical Ingredient Products Offered
12.16.5 BASF SE Recent Development
12.17 Catalent Inc.
12.17.1 Catalent Inc. Corporation Information
12.17.2 Catalent Inc. Business Overview
12.17.3 Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Products Offered
12.17.5 Catalent Inc. Recent Development
12.18 Teva Pharmaceuticals
12.18.1 Teva Pharmaceuticals Corporation Information
12.18.2 Teva Pharmaceuticals Business Overview
12.18.3 Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Products Offered
12.18.5 Teva Pharmaceuticals Recent Development
12.19 Roche
12.19.1 Roche Corporation Information
12.19.2 Roche Business Overview
12.19.3 Roche Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Roche Small Molecule Active Pharmaceutical Ingredient Products Offered
12.19.5 Roche Recent Development
12.20 Cambrex Corporation
12.20.1 Cambrex Corporation Corporation Information
12.20.2 Cambrex Corporation Business Overview
12.20.3 Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Products Offered
12.20.5 Cambrex Corporation Recent Development
12.21 GILEAD Science Inc.
12.21.1 GILEAD Science Inc. Corporation Information
12.21.2 GILEAD Science Inc. Business Overview
12.21.3 GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
12.21.4 GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Products Offered
12.21.5 GILEAD Science Inc. Recent Development
13 Small Molecule Active Pharmaceutical Ingredient Manufacturing Cost Analysis
13.1 Small Molecule Active Pharmaceutical Ingredient Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Small Molecule Active Pharmaceutical Ingredient
13.4 Small Molecule Active Pharmaceutical Ingredient Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Small Molecule Active Pharmaceutical Ingredient Distributors List
14.3 Small Molecule Active Pharmaceutical Ingredient Customers
15 Market Dynamics
15.1 Small Molecule Active Pharmaceutical Ingredient Market Trends
15.2 Small Molecule Active Pharmaceutical Ingredient Opportunities and Drivers
15.3 Small Molecule Active Pharmaceutical Ingredient Market Challenges
15.4 Small Molecule Active Pharmaceutical Ingredient Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Small Molecule Active Pharmaceutical Ingredient Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Region (2015-2020)
Table 5. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region (2015-2020)
Table 6. Global Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Region (2015-2020)
Table 8. Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share Forecast by Region (2021-2026)
Table 12. Global Small Molecule Active Pharmaceutical Ingredient (MT) of Key Companies (2015-2020)
Table 13. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Company (2015-2020)
Table 14. Global Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Company (2015-2020)
Table 16. Global Small Molecule Active Pharmaceutical Ingredient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Active Pharmaceutical Ingredient as of 2019)
Table 17. Global Small Molecule Active Pharmaceutical Ingredient Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Small Molecule Active Pharmaceutical Ingredient Manufacturing Sites and Area Served
Table 19. Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Small Molecule Active Pharmaceutical Ingredient Players
Table 22. Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Type (2015-2020)
Table 23. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Type (2015-2020)
Table 24. Global Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Small Molecule Active Pharmaceutical Ingredient Price (MT) by Type (2015-2020)
Table 26. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Type (2021-2026)
Table 27. Global Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Type (2021-2026)
Table 29. Global Small Molecule Active Pharmaceutical Ingredient Price (MT) by Type (2021-2026)
Table 30. Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Application (2015-2020)
Table 31. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Application (2015-2020)
Table 32. Global Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Small Molecule Active Pharmaceutical Ingredient Price (MT) by Application (2015-2020)
Table 34. Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Application (2021-2026)
Table 35. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Application (2021-2026)
Table 36. Global Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Application (2021-2026)
Table 38. Global Small Molecule Active Pharmaceutical Ingredient Price (MT) by Application (2021-2026)
Table 39. United States Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Company (2015-2020)
Table 40. United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company (2015-2020)
Table 41. United States Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Type (2015-2020)
Table 42. United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 43. United States Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Application (2015-2020)
Table 44. United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 45. Europe Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Company (2015-2020)
Table 46. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company (2015-2020)
Table 47. Europe Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Type (2015-2020)
Table 48. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 49. Europe Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Application (2015-2020)
Table 50. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 51. China Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Company (2015-2020)
Table 52. China Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company (2015-2020)
Table 53. China Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Type (2015-2020)
Table 54. China Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 55. China Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Application (2015-2020)
Table 56. China Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 57. Japan Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Company (2015-2020)
Table 58. Japan Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company (2015-2020)
Table 59. Japan Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Type (2015-2020)
Table 60. Japan Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 61. Japan Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Application (2015-2020)
Table 62. Japan Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 69. India Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Company (2015-2020)
Table 70. India Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company (2015-2020)
Table 71. India Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Type (2015-2020)
Table 72. India Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 73. India Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Application (2015-2020)
Table 74. India Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 75. Johnson Matthey Corporation Information
Table 76. Johnson Matthey Description and Business Overview
Table 77. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Product
Table 79. Johnson Matthey Recent Development
Table 80. Siegfried Holding AG Corporation Information
Table 81. Siegfried Holding AG Description and Business Overview
Table 82. Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Product
Table 84. Siegfried Holding AG Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Pfizer Small Molecule Active Pharmaceutical Ingredient Product
Table 89. Pfizer Recent Development
Table 90. Sanofi S.A. Corporation Information
Table 91. Sanofi S.A. Description and Business Overview
Table 92. Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Product
Table 94. Sanofi S.A. Recent Development
Table 95. Novartis AG, Corporation Information
Table 96. Novartis AG, Description and Business Overview
Table 97. Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Novartis AG, Small Molecule Active Pharmaceutical Ingredient Product
Table 99. Novartis AG, Recent Development
Table 100. Bristol-Myers Squibb Corporation Information
Table 101. Bristol-Myers Squibb Description and Business Overview
Table 102. Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Product
Table 104. Bristol-Myers Squibb Recent Development
Table 105. Boehringer Ingelheim GmbH Corporation Information
Table 106. Boehringer Ingelheim GmbH Description and Business Overview
Table 107. Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Product
Table 109. Boehringer Ingelheim GmbH Recent Development
Table 110. GlaxoSmithKline Corporation Information
Table 111. GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. GlaxoSmithKline Description and Business Overview
Table 113. GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Product
Table 114. GlaxoSmithKline Recent Development
Table 115. Albany Molecular Research Inc. Corporation Information
Table 116. Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Albany Molecular Research Inc. Description and Business Overview
Table 118. Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Product
Table 119. Albany Molecular Research Inc. Recent Development
Table 120. Bachem Holding AG Corporation Information
Table 121. Bachem Holding AG Description and Business Overview
Table 122. Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Product
Table 124. Bachem Holding AG Recent Development
Table 125. PCAS Corporation Information
Table 126. PCAS Description and Business Overview
Table 127. PCAS Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. PCAS Small Molecule Active Pharmaceutical Ingredient Product
Table 129. PCAS Recent Development
Table 130. Patheon N.V. Corporation Information
Table 131. Patheon N.V. Description and Business Overview
Table 132. Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Product
Table 134. Patheon N.V. Recent Development
Table 135. AstraZeneca Corporation Information
Table 136. AstraZeneca Description and Business Overview
Table 137. AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. AstraZeneca Small Molecule Active Pharmaceutical Ingredient Product
Table 139. AstraZeneca Recent Development
Table 140. Johnson & Johnson Corporation Information
Table 141. Johnson & Johnson Description and Business Overview
Table 142. Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Product
Table 144. Johnson & Johnson Recent Development
Table 145. Merck & Co Corporation Information
Table 146. Merck & Co Description and Business Overview
Table 147. Merck & Co Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Merck & Co Small Molecule Active Pharmaceutical Ingredient Product
Table 149. Merck & Co Recent Development
Table 150. BASF SE Corporation Information
Table 151. BASF SE Description and Business Overview
Table 152. BASF SE Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. BASF SE Small Molecule Active Pharmaceutical Ingredient Product
Table 154. BASF SE Recent Development
Table 155. Catalent Inc. Corporation Information
Table 156. Catalent Inc. Description and Business Overview
Table 157. Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Product
Table 159. Catalent Inc. Recent Development
Table 160. Teva Pharmaceuticals Corporation Information
Table 161. Teva Pharmaceuticals Description and Business Overview
Table 162. Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 163. Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Product
Table 164. Teva Pharmaceuticals Recent Development
Table 165. Roche Corporation Information
Table 166. Roche Description and Business Overview
Table 167. Roche Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 168. Roche Small Molecule Active Pharmaceutical Ingredient Product
Table 169. Roche Recent Development
Table 170. Cambrex Corporation Corporation Information
Table 171. Cambrex Corporation Description and Business Overview
Table 172. Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 173. Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Product
Table 174. Cambrex Corporation Recent Development
Table 175. GILEAD Science Inc. Corporation Information
Table 176. GILEAD Science Inc. Description and Business Overview
Table 177. GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 178. GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Product
Table 179. GILEAD Science Inc. Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Small Molecule Active Pharmaceutical Ingredient Distributors List
Table 183. Small Molecule Active Pharmaceutical Ingredient Customers List
Table 184. Small Molecule Active Pharmaceutical Ingredient Market Key Trends
Table 185. Small Molecule Active Pharmaceutical Ingredient Key Opportunities and Drivers
Table 186. Small Molecule Active Pharmaceutical Ingredient Market Challenges
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Small Molecule Active Pharmaceutical Ingredient Product Picture
Figure 2. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2020 & 2026
Figure 6. Cardiovascular Diseases Examples
Figure 7. Respiratory Disorders Examples
Figure 8. Infectious Diseases Examples
Figure 9. Others Examples
Figure 10. Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) Growth Rate (2015-2026)
Figure 11. Global Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Small Molecule Active Pharmaceutical Ingredient Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Small Molecule Active Pharmaceutical Ingredient Sales (MT) Growth Rate (2015-2026)
Figure 17. Europe Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Small Molecule Active Pharmaceutical Ingredient Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Small Molecule Active Pharmaceutical Ingredient Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Small Molecule Active Pharmaceutical Ingredient Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Small Molecule Active Pharmaceutical Ingredient Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Small Molecule Active Pharmaceutical Ingredient Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Small Molecule Active Pharmaceutical Ingredient Players Market Share by Revenue in Small Molecule Active Pharmaceutical Ingredient 2015 & 2019
Figure 28. Small Molecule Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Type (2015-2020)
Figure 30. Global Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Application (2015-2020)
Figure 32. Global Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type in 2019
Figure 34. United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type in 2019
Figure 35. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company in 2019
Figure 36. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type in 2019
Figure 37. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application in 2019
Figure 38. China Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company in 2019
Figure 39. China Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type in 2019
Figure 40. China Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application in 2019
Figure 41. Japan Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company in 2019
Figure 42. Japan Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type in 2019
Figure 43. Japan Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application in 2019
Figure 44. Southeast Asia Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company in 2019
Figure 45. Southeast Asia Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type in 2019
Figure 46. Southeast Asia Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application in 2019
Figure 47. India Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company in 2019
Figure 48. India Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type in 2019
Figure 49. India Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Small Molecule Active Pharmaceutical Ingredient
Figure 52. Manufacturing Process Analysis of Small Molecule Active Pharmaceutical Ingredient
Figure 53. Small Molecule Active Pharmaceutical Ingredient Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
低分子がん治療薬の世界市場レポート2020 Market Analysis and Insights: Global Small Molecule Cancer Drug Market The global Small Molecule Cancer Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Small Molecule Cancer Drug Scope and Market Size The global Sm…- プレフィルドシリンジ小分子の世界市場レポート2020 Market Analysis and Insights: Global Prefilled Syringe Small Molecule Market The global Prefilled Syringe Small Molecule market size is projected to reach US$ 13420 million by 2026, from US$ 10350 million in 2020, at a CAGR of 4.4% during 2021-2026. Global Prefilled Syringe Small Molecule Scope and …
- API（医薬品有効成分）中間体の世界市場レポート2020 Market Analysis and Insights: Global API(Active Pharmaceutical Ingredient) Intermediate Market The global API(Active Pharmaceutical Ingredient) Intermediate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global API(Active Pha…
- 化粧品有効成分の世界市場レポート2020 Cosmetics are not allowed to have drug effects. So in cosmetics, the term “active ingredient” is a marketing term for an ingredient that people believe has some effect but is not legally allowed to. For example, some marketers say Vitamin C is an active ingredient for skin lightening. The major prod…
- 医薬品有効成分（API）の世界市場レポート2020 An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain m…